
WASHINGTON, March 7, 2008
Prescription For Profit
Meet The Whistleblower Who Exposed A Hospital's Dangerous, And Costly, Pill Swapping
-
Play CBS Video Video A Doctor's Fight Pays Off It's a David and Goliath story between one doctor and a widespread medical practice, one that puts profit ahead of health and costs taxpayers millions of dollars. Sharyl Attkisson reports.
-
-
William LaCorte blew the whistle on one New Orleans hospital's prescription-swapping scheme, which was costing taxpayers big. (CBS)
-
(CBS/iStockphoto)
-
-
Interactive HealthWatch Explore health issues including AIDS, cancer and antibiotics.
-
Blog Primary Source Armen Keteyian and his investigative team keep you informed daily on their blog.

• Murtha's Defense Earmarks Questioned
• Bailout Banks Hike Up Charges
• Student Loan Charity Under Fire
• Bailout Money To Tax Havens
• Big Bank's Bailout Spending Spree
• The Impossible-To-Track Bailout
• Where Did The Bailout Billions Really Go?
• Pension System A Runaway Train
• Parking Garage To Nowhere
• Did D.C. Bribery Cost Troop Lives?
• Teach For America Gets Schooled
• USDA Jobs A Day At The Beach?
• From Lawmaker To Lobbyist
• Flying The Empty Skies
• Fishing For Tax $$
• Millions In Pills, Flushed
"It's amazing that any pharmaceutical reps call on me at all," he said.
He's been fighting a one-man battle against a widespread medical practice. It puts profit ahead of health and costs you hundreds of millions of dollars, CBS News correspondent Sharyl Attkisson reports.
"I may be just a big pain in the ass," he said.
It started when he caught Memorial Hospital in New Orleans doing something very odd.
Every time he prescribed Zantac, the hospital changed it to Pepcid. Both are acid blockers than can prevent dangerous internal bleeding.
"I said, 'why is it I'm ordering one drug and a totally different drug is being given?'" LaCorte said. "And I was told 'therapeutic interchange.'"
Therapeutic interchange meant the hospital was switching virtually all antacid prescriptions to Pepcid. And it wasn't a meaningless change.
While LaCorte says Pepcid is a good drug, it was given in doses that were too strong for some patients, making them very sick. One even went into a coma.
When he tried to find out why so many were given Pepcid, he discovered Memorial Hospital had made what's called a "market share" deal with Merck, the maker of the drug. As long as 80 percent of patients were on Pepcid, Merck gave the hospital a deep discount.
The hospital's task was to get almost all of the patients who needed that type of drug on the Merck brand drug, according to LaCorte.
LaCorte complained to everyone he could think of … without result.
Finally, he got the feds involved - by proving taxpayers were being defrauded. It turns out the Pepcid cost twice as much as Zantac, and since many patients were on Medicaid or Medicare, taxpayers covered the extra cost.
The fight took 12 long years, but Merck recently agreed to pay back taxpayers $650 million for deals to get hospitals nationwide to favor not only Pepcid, but also Merck drugs Zocor and Vioxx.
Under U.S. law for whistleblowers, LaCorte will get a sizable payment from the recovered money.
"This is a widespread practice with multiple medications," he said. "This is business-as-usual for the hospitals and drug companies in the United States of America today."
LaCorte says taking them on is tougher than fighting City Hall.
But he's just the doctor with the bedside manner to do it.
© MMVIII, CBS Interactive Inc. All Rights Reserved.
Best-selling author Mitch Albom on his first nonfiction work since "Tuesdays with Morrie."





- 1
- 2
- 3
- next
See all 54 CommentsIf you follow the money, it''s clear that the hospital''s saving money because they''re getting a kick-back from Merck. And Merck is making money because they''re selling more goods. The average medicare patient is unaffected, because they wouldn''t be paying for their drugs anyway. The money that Merck, and consequently the hosptial, are making comes from the taxpayer.
I''m not on medicare, I pay for my own drugs through insurance or directly. If I were particularly vigilant, I might notice that I could save more money in the long term by getting the prescription from a non-hosptial pharmacy, just as I might buy clothes from a store that had a sale. That''s how capitalism works.
However, a medicare patient has no incentive to save money, and in all likelihood may be too old to seek out a cheaper price.
Neither the hosptial, nor Merck, nor patients have a direct incentive to blow the whistle, even though taxpayers are losing out. That''s why Lacorte did an admirable deed, and deserves a financial reward.
I''ve lost respect for Katie and the CBS news for this horrible story........
Frankly, I do not want some hospital board, or any other person deciding my health care. I pay a doctor for his services, and I expect to get the treatment that he prescribes for me.
Corporate decisions should not enter into the health care of patients!
"The world is insane!!" posted by ssm9451
Ahh, I don''t know about the world, but the U.S. certaintly is!
I guess that picking on a hospital in New Orleans is enough to catch the attention of you audience, but telling the hole truth about the piece will keep them.
Often, TI is an alternative to the massive marketing of drugs to doctors and that costs taxpayers many, many more millions than TI. TI more often than not substitutes a generic drug for a brand name drug.
TI is a way for hospitals to cut costs, allowing any doctor to prescibe any medication would increase the already astronomic cost of hospital care and not improve the quality of care.
What as it come to when we lie in bed sick and helpless relying upon thieving maniacs who have sold our life and well being for ten bucks.
The threat of Osama Bin Laden pales into insignificance as compared to the these evil crooks.
This cartel killed far more people last year than the Mad Mullar did. The people must act before it gets worse.
Sounds a lot like me. Geesh.
- 1
- 2
- 3
- next
See all 54 Comments